Welcome to Seagull Pharmacy!
Current Location:Home>Medical Information>Deucravatinib Medication Guidelines
Deucravatinib Medication Guidelines
Publisher:海鸥医学顾问     Publication Date:2026-09-10 16:25      The article comes from the Internet

Deucravatinib is an oral targeted drug, and standardized medication is the basis for ensuring efficacy and safety. The following are specific points for taking.

1、 Conventional dress code

Take once a day at a fixed time.

Available with meals or on an empty stomach, unaffected by eating.

Swallow the whole tablet, do not crush, pry open or chew.

2、 Handling of missed services

If it is too early to take the next medication, you can take it immediately.

If it is close to the next medication time, skip the missed dose.

Take once the next day according to the original time, do not double the dosage.

3、 Dose adjustment

The regular dosage should follow the doctor's advice and cannot be increased or decreased by oneself.

Contact a doctor promptly when there is obvious discomfort or abnormal reaction.

The adjustment of dosage must be determined by the doctor based on specific circumstances.

Individuals with abnormal liver and kidney function should inform their doctor before taking medication.

4、 Precautions

Regular follow-up visits during medication and monitoring of relevant indicators according to medical advice.

Avoid indiscriminate combination with other medications and consult a doctor before use.

Pregnant women, breastfeeding mothers, and those planning to conceive should inform their doctors in advance.

If medication is frequently missed or difficult to take, one should proactively communicate with a doctor.

Standardized medication and timely feedback are the key to safe medication.

Disclaimer:《Deucravatinib Medication Guidelines》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication!

Related Drugs

Deucravacitinib

Full Name:Deucravacitinib、Sotyktu、氘可来昔替尼、颂狄多、

Reference Price:$569.00

Prescribing Information: 银屑病是一种免疫介导的慢性、系统性、炎症性疾病,其核心发病通路受到Janus激酶(JAK)家族介导的JAK-STAT通路的调控。 Ⅰ.药品名称 商品名:SOTYKTU™ 通用名:氘可来昔替尼(Deucravacitinib) Ⅱ.适应症 用于治疗适合系统治疗或...